|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Essentialis, Inc.
| | | Phone: | (760) 444-0446 | Year Established: | 2003 | Ticker: | CAPN | Exchange: | NASDAQ | Main Contact: | Neil M. Cowen, PhD, MBA, President & CSO | | Company Description | Essentialis is a privately-held clinical-stage pharmaceutical company focused on the development of breakthrough medicines for the treatment of rare metabolic diseases where there is increased mortality and risk of cardiovascular and endocrine complications.
On March 8, 2017, Capnia announced that it has completed its previously-announced merger with privately-held Essentialis. Concurrent with the merger closing, prior investors in Essentialis, as well as new investors, invested $10 million in newly-issued Capnia shares of common stock at $0.96 per share. | |
|
|
|
|
|